Osaic Holdings
DFTX

Osaic Holdings’s Definium Therapeutics DFTX Stock Holding History

Osaic Holdings’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Buy
11,952
+1,393
+13% +$34.4K ﹤0.01% 3561
2026
Q1 		$200K Buy
10,559
+32
+0.3% +$543 ﹤0.01% 4138
2025
Q4 		$141K Sell
10,527
-1,075
-9% -$13.3K ﹤0.01% 4423
2025
Q3 		$126K Sell
11,602
-5,849
-34% -$54.5K ﹤0.01% 4588
2025
Q2 		$113K Sell
17,451
-72
-0.4% -$474 ﹤0.01% 4407
2025
Q1 		$103K Buy
17,523
+7,277
+71% +$52.1K ﹤0.01% 4150
2024
Q4 		$71.2K Buy
10,246
+2,270
+28% +$15.6K ﹤0.01% 4430
2024
Q3 		$45.4K Buy
7,976
+3,742
+88% +$26K ﹤0.01% 4819
2024
Q2 		$30.5K Buy
4,234
+493
+13% +$4.31K ﹤0.01% 5047
2024
Q1 		$35.2K Buy
3,741
+464
+14% +$2.65K ﹤0.01% 4977
2023
Q4 		$12K Sell
3,277
-1,638
-33% -$4.93K ﹤0.01% 5745
2023
Q3 		$15.4K Buy
4,915
+1,152
+31% +$4.74K ﹤0.01% 5691
2023
Q2 		$13.5K Sell
3,763
-311
-8% -$1.07K ﹤0.01% 5809
2023
Q1 		$12.9K Sell
4,074
-25
-0.6% -$83 ﹤0.01% 5823
2022
Q4 		$9.4K Buy
4,099
+2,308
+129% +$6.41K ﹤0.01% 5971
2022
Q3 		$6K Buy
1,791
+424
+31% +$4.07K ﹤0.01% 6282
2022
Q2 		$13K Buy
1,367
+858
+169% +$10.9K ﹤0.01% 5905
2022
Q1 		$9K Sell
509
-393
-44% -$6.82K ﹤0.01% 6211
2021
Q4 		$19K Sell
902
-3,984
-82% -$127K ﹤0.01% 5832
2021
Q3 		$172K Buy
4,886
+2,467
+102% +$107K ﹤0.01% 4040
2021
Q2 		$124K Buy
+2,419
New +$127K ﹤0.01% 4296

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Osaic Holdings's DFTX Position: Q2 2026 in Review

Osaic Holdings increased its Definium Therapeutics (DFTX) stake by 13% in Q2 2026, buying an estimated $34.4K and bringing the position to 11,952 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

Osaic Holdings first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Osaic Holdings held 11,952 shares of Definium Therapeutics worth $562K as of Q2 2026.
  • Osaic Holdings bought 1,393 Definium Therapeutics shares in Q2 2026, an estimated $34.4K.
  • Definium Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3561 holding.
  • Osaic Holdings first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.